TCI Wealth Advisors, Inc. - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$189
-57.7%
100
-66.7%
0.00%
Q4 2022$447
-55.3%
3000.0%0.00%
Q3 2022$1,0000.0%3000.0%0.00%
Q2 2022$1,0000.0%3000.0%0.00%
Q1 2022$1,0000.0%3000.0%0.00%
Q4 2021$1,0000.0%300
+50.0%
0.00%
Q3 2021$1,0000.0%2000.0%0.00%
Q2 2021$1,000
-66.7%
200
-50.0%
0.00%
-100.0%
Q1 2021$3,000
-50.0%
400
-20.0%
0.00%
-66.7%
Q4 2020$6,000
+100.0%
5000.0%0.00%
+200.0%
Q3 2020$3,0005000.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$848,0820.28%
Ikarian Capital, LLC 2,765,530$492,2650.06%
JOHNSON & JOHNSON 84,003$14,9530.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$46,0740.00%
BlackRock Inc. 267,821$47,6730.00%
Bank of New York Mellon Corp 10,259$1,8260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,835$2,8190.00%
Truvestments Capital LLC 318$570.00%
Tower Research Capital LLC (TRC) 10,407$1,8520.00%
Cutler Group LLC / CA 1,200$00.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders